Related Experiment Video

Updated: Sep 3, 2026

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
09:57

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on: March 5, 2018

Cytomorphological and cytochemical classification of acute myeloid leukaemia (AML)

J Maras, E Hauptmann, I Crepinko

    Folia Haematologica (Leipzig, Germany : 1928)
    |January 1, 1986
    PubMed

    Insights

    This study refined the French-American-British (FAB) classification for adult acute myeloid leukemia (AML) by integrating cytomorphological and cytochemical analyses. Key AML groups M-1 and M-4 required reclassification for improved diagnostic accuracy.

    Area of Science:

    • Hematology
    • Oncology
    • Cell Biology

    Background:

    • The French-American-British (FAB) classification is a standard for acute myeloid leukemia (AML).
    • Cytomorphological and cytochemical analyses are crucial for leukemia subtyping.

    Purpose of the Study:

    • To evaluate and refine the FAB classification of adult AML.
    • To determine the necessity of integrating cytochemical data with cytomorphology for accurate AML classification.

    Main Methods:

    • Cytomorphological classification using the FAB system on 100 adult AML cases.
    • Cytochemical classification using Loeffler's staining method.
    • Combined analysis of cytomorphological and cytochemical data.

    Main Results:

    • The combined analysis revealed discrepancies in the current FAB classification.
    • Specific reclassifications were necessary for FAB groups M-1 and M-4.
    • Cytochemical analysis provided essential data for refining AML subtypes.

    Conclusions:

    • The FAB classification requires adjustments based on integrated cytomorphological and cytochemical findings.
    • A definitive FAB classification for AML should incorporate both analytical methods.
    • This integrated approach enhances the precision of AML subtyping and classification.

    More Related Videos

    Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up09:01

    Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

    Published on: March 26, 2018

    Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants07:38

    Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

    Published on: June 6, 2025

    Related Concept Videos

    Differentiation of Common Myeloid Progenitor Cells01:15

    Differentiation of Common Myeloid Progenitor Cells

    Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
    Classification of Leukocytes01:30

    Classification of Leukocytes

    Leukocytes are classified into two groups based on the presence or absence of cytoplasmic granules. Granular leukocytes, which contain granules, belong to the myeloid lineage and are divided into three subtypes: neutrophils, eosinophils, and basophils. These cells are roughly spherical and characterized by the granules in their cytoplasm.
    Neutrophils are the most abundant type of granular leukocytes, comprising 50-70% of all leukocytes. They feature small, evenly distributed granules and a...
    Disorders of Leukocytes01:27

    Disorders of Leukocytes

    Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
    Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...